Rocuronium Bromide is an aminosteroid, non-depolarising neuromuscular blocking agent prized for its rapid onset and intermediate duration of action during anaesthesia and tracheal intubation. Its reversibility with sugammadex has cemented its role in modern surgical practice. Simson Pharma's Rocuronium Bromide reference standard, alongside its pharmacopoeial impurities, supports the stringent quality control demanded of injectable anaesthetic agents.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Rocuronium Bromide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.